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Full-field digital mammography システムにおける異なる乳腺密度とコントラスト雑音比の検討 
 
医療科学専攻   中村 哲子 
（指導教員 ： 奥田 逸子客員教授） 
【はじめに】 
乳房は乳腺と脂肪組織から成り、乳腺は脂肪組織と比べ X 線の透過性が低い。マンモグラフィ(以下、
MMG)では乳腺と脂肪組織の X 線減弱の差が画像のコントラストとなる。MMG における乳癌の検出に乳
腺密度が大きく関係する。また、乳腺密度の高い高濃度乳腺は、乳癌の検出感度を低下させる。 
MMG の被ばくは皮膚表面ではなく計算値である平均乳腺線量（Average glandular dose ; AGD）で表さ
れる。AGD は予測変数であり、さらに画質と線量はトレードオフの関係にある。乳腺密度の違いによる
MMG の画質評価に関する報告は少ない。画質の物理的指標の一つであるコントラスト雑音比（Contrast 
to noise ratio ; CNR）と乳腺密度の関係を数値化することは、検出感度が低下する高濃度乳腺の乳癌診
断において有益なデータとなり得る。完全な画像評価は複数の測定方法を必要とするため、MMG にお
ける画質評価の指標の一つとして用いられる CNR と AGD との複雑な関係は完全に解明されていない。
我々は AGD と CNR との相関がファントム研究から解明できれば、MMG の撮影中にこの知識を適用して、
乳癌診断の信頼性を向上するためのツールとして使用できると仮定する。 
【目的】 
乳房撮影装置（Full-field digital mammography : FFDM）において、乳腺密度、乳房の厚さ、AGD が
CNR に及ぼす影響について検討し、AGD と乳腺密度を用いて CNR を高精度に予測する計算式を開発
する。 
【方法】 
General Electric 社製 FFDM システムおよび異なる乳腺密度（乳腺/脂肪）を有する 3 種類の乳房モデ
ル A(30/70)、B（50/50）、C（70/30）の乳房等価ファントムを使用した。5mm、10mm、20mmの厚さのファン
トムを組み合わせ、10m から 70mm までの 7 つの厚さの乳房モデルを作成した。ファントム撮影はターゲッ
ト/付加フィルタおよび管電圧を自動的に選択する自動露出機構を用いた。装置に表示されたファントム
画像の撮影条件（管電圧、管電流時間積、AGD）を記録した。各乳房モデルは 3 回撮影し、各表示値の
平均値をCNR計算に用いた。CNR測定は IEC61223-3-2Ed.2.0 に記載されたガイドラインに従って実施
した。100mm×100mm×0.2mm サイズの 99.9%高純度アルミニウム板をコントラスト物質としてファントムの
中心に配置した。撮影した画像は各乳房モデルの中心にアルミニウム板あり、またはなしの 2 種類であっ
た。得られた 2 種類の画像について、乳房支持台ユニットの胸壁端から 60ｍｍ離れた乳頭側で X 線管
長軸方向の中央線上に対応する 20ｍｍ×20ｍｍの矩形関心領域(ROI)を設定し、Image J ソフトウェアを
用いてアルミニウム板あり、またはなしの二つの画像の ROI 内の平均画素値を測定した。測定された画
素値から数式に従い CNR 値を算出した。統計解析には SAS 社製統計ソフトウェア JMP ver13.1.0 を用
いた。Excel 関数を使用して、各乳腺密度について予測式を得た。二乗平均平方根誤差（RMSE）分析を
用いて、AGD によって調整された CNR の予測値を、各乳腺密度についての実際の CNR 値と比較するこ
とによって、予測精度を評価した。
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【結果】 
CNR 値は、全ての厚さで乳房モデル A（30/70）において最も高かった。より低い乳腺密度およ
びより低い乳房モデル厚さでより高い CNR 値が得られた。 3 つの乳房モデル間の CNR の変動は、
より低いファントム厚さ（10〜30mm）では低い（変動係数、3.4〜8.7％）が、より高いファントム厚さで
は高い（変動係数、10.5〜16.8％ 50~70mm）。特に、乳房モデルの厚さが 70mm の場合、乳房モ
デル C（70/30）の CNR は乳房モデル A（30/70）のそれに比べて相対的に 26％低かった。乳腺密
度および AGD の p 値はそれぞれ 0.0476 および<0.0001 であり、統計的有意差を示した。結果は、
乳腺密度および AGD の両方が CNR の重要な予測因子であることを示した。乳房モデル A
（30/70 ）と C（70/30）は両モデル間の CNR に統計学的有意差を示した。3 つの乳腺密度はすべ
てにおいて、CNR と AGD との間に強い負の相関（r = -0.8989）があった。CNR 予測式は次式のよ
うに得られた。CNR = -10.81×AGD + 各乳腺密度の係数 + 27.1 
この予測式は r2 = 0.865 および二乗平均平方根誤差（RMSE） = 1.893 であり、AGD、乳腺密度を
用いて CNR を予測することが可能であることを示した。 
【考察】 
CNR は様々な画像診断装置における画質の指標と考えられている。画像処理および画像表示
はデジタル画像機器の画質に影響を与えるため、画像を物理的に評価し画質を評価することは重
要である。したがって、画質の唯一の指標として CNR を使用することは理想的ではない。本研究で
は、乳房等価ファントムを用いて乳房 X 線撮影の異なる組織密度と厚さに基づく CNR と AGD を検
討した。我々の結果は、より低い乳腺組密度およびより低い厚さを有する乳房ファントムでより高い
CNR 値が得られたことを示した。これらの結果は、MMG 画像の品質が高密度の乳房ではより劣っ
ているという以前からの知見を裏付けている。さらに、MMGにおける乳房の厚さのCNRと画質の関
係を明らかにしている。 
 多変量解析では、乳腺密度および AGD の両方が CNR の重要な予測因子であり、AGD は CNR
に大きな影響を与えることが示された。 CNR は、合理的に高い精度（r2 は 0.865、RMSE は 1.893）
で、AGD と乳腺密度を用いた予測式によって計算することができた。異なる乳腺密度を有する乳
房モデル間で、CNR の統計的に有意な差が観察された。 3 つの乳腺密度すべてにおいて、CNR
と AGD との間に強い負の相関が見出された。 FFDM システムを使用して AGD および乳腺密度情
報から CNR を容易かつ正確に予測するための CNR 予測式が構築された。 CNR と乳腺密度、
AGD、およびファントム厚さとの相関を評価することを目的とした多変量線形回帰分析モデルは、
乳腺密度およびファントム厚さと CNR との間に有意な相関を示した。しかし、解析モデルに組み込
まれた各変数が独立していることを保証する必要があり、解析モデルに関連する変数を同時に組
み込むと結果が悪化することが知られている。したがって、ファントム厚さを組み込んだ第 1 のモデ
ルと AGD を組み込んだ第 2 のモデルの 2 つの追加モデルを使用して回帰分析を行った。臨床で
は、CNRに類似した観察項目を測定することが困難であり、臨床応用の観点から AGDを説明変数
として使用することが重要であることに留意されたい。 
【結論】 
FFDMシステムにおいて、乳腺密度、乳房の厚さ、AGDがCNRにおよぼす影響について検討し
た。そして、CNR が AGD および乳腺密度を用いて高精度に予測可能であると示唆された。乳腺密
度に基づく CNR 予測は、乳癌診断における MMG の診断信頼性を数値化し、乳腺密度が CNR に
及ぼす影響を客観的に管理し、乳癌診断の信頼性を向上するためのツールとして期待できる。 
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1. Abstract 
We aimed to investigate the effects of mammary gland density and average glandular dose (AGD) on 
contrast-to-noise ratio (CNR) of breast-equivalent phantoms with different mammary gland/fat tissue 
ratios. Full-field digital-mammography breast X-rays were performed on breast-equivalent phantoms 
with three different mammary gland/fat tissue ratios (Phantom A [30/70], Phantom B [50/50], and 
Phantom C [70/30]) and seven thicknesses ranging from 10 mm to 70 mm. The prediction formula for the 
CNR was calculated by multivariate analysis and the effects of the various parameters on CNR were 
evaluated using a multiple regression analysis model. Higher CNR values were obtained with lower 
mammary gland/fat tissue ratios and lower phantom thicknesses. Variation in CNR among the three 
breast models was low (coefficient of variation, 3.4–8.7%) at lower phantom thicknesses (10–30 mm), and 
high (coefficient of variation, 10.5–16.8%) at higher phantom thickness (50–70 mm). CNR showed a strong 
negative correlation (r = -0.8989) with AGD across all three mammary gland ratios. A predictive formula 
for CNR using AGD and mammary gland density was developed. CNR can be predicted with high 
precision using AGD and mammary gland density. The predicted CNR could be used to measure the 
diagnostic reliability of mammography in breast cancer. 
 
2. Key word 
Average Glandular Dose, Contrast to Noise Ratios, Full-Field Digital Mammography,  
Different Breast Densities 
 
3. Introduction  
Early detection of breast cancer though mammographic screening has significantly reduced breast 
cancer mortality [1]. Since mammary glands are less permeable to X-rays than fat tissue in the breast, 
mammography (MMG) essentially creates a contrast image of the breast based on differences in X-ray 
attenuation by different tissue components [2]. The area ratio of mammary gland tissue to the fat tissue 
within the entire breast mammogram is referred to as the mammary gland density in MMG. Breast density 
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is a significant factor in the reliability of breast cancer diagnosis for two reasons. Dense breast tissue has 
not only been demonstrated to be a risk factor for breast cancer in Western [3-9] and Japanese women 
[10-12], it is also known to reduce the detection sensitivity of breast cancer in clinical settings [13]. Kolb 
et al. [13] reported that the detection 
sensitivity of cancer in low-density mammary gland tissue is 83%–98% compared to 48%–64% in dense 
breast tissue. 
Considering the importance of breast density in cancer diagnosis and risk evaluation, the American 
College of Radiology has proposed a Breast Imaging Reporting and Data System (BI-RADS) classification 
system for standardized interpretation and reporting of mammograms [14]. As per the latest version, 
lesions are classified into six grades, including two high-risk grades that pertain to highly dense mammary 
gland breast tissue. Appropriate diagnosis depends not only on proper interpretation but also on good 
mammogram image quality [15]. Identifying breast cancer in dense breast tissue is challenging because of 
the masking effect of the mammary glands, which results in poor image quality in dense breasts [8,16,17]. 
Currently, most mammography equipment uses full field digital mammography (FFDM), which has a high 
detection quantum efficiency. FFDM enables the acquisition of images suitable for diagnosis with the 
addition of image processing, even in thickened breast tissue. Such imaging has been shown to be 
effective in breast cancer screening in dense breasts [18]. 
One of the physical indicators of digital imaging quality is contrast to noise ratio (CNR) [19]. CNR is used 
to manage the precision of digital equipment and to compare their performance. By increasing the 
exposure and average glandular dose (AGD) of radiation, the MMG image quality in dense breast tissue 
can be improved [20]. There is, however, a trade-off relationship between image quality and exposure. To 
optimize image quality, especially in thick breast tissues, it is important to understand the complex 
relationship between the CNR and AGD in MMG. Breast-equivalent phantoms mimic the 3-dimensional 
structure of the human breast and offer an attractive option to study the variation of CNR and AGD with 
different breast thicknesses [21]. Breast phantoms are available in different thicknesses and tissue ratios 
corresponding to varying mammary gland densities and have been extensively used for MMG imaging 
studies [22,23]. A previous study using breast phantoms showed AGD increases with increasing breast 
thickness [24]. Another study with breast phantoms showed that with increased breast thickness, AGD 
values increase and CNR values decrease [25]. The aim of this study was to corroborate the relationship 
between CNR, mammary gland ratio, AGD, and phantom thickness using breast phantoms of varying 
thickness. We hypothesized that the correlation of AGD and CNR could be applied to clinical settings to 
enable the acquisition of images with an optimal trade-off between image quality and radiation dose. 
 
4. Materials and Methods 
An FFDM breast X-ray device and three types of breast-equivalent phantoms with different tissue 
ratios were used. The prediction formula for the CNR was calculated by multivariate analysis, and the 
effects of the various mammary gland densities and AGD on CNR were evaluated using a statistical 
analysis model.  
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4.1. Breast-Equivalent Phantoms 
Breast-equivalent phantoms (Eastek Breast Phantom Research Set CI RS Model 14A, Norfolk, VA) 
of three mammary gland/fat tissue ratios were used: Phantom A (30/70), Phantom B (50/50), and 
Phantom C (70/30). By combining individual phantoms of 5-mm, 10-mm and 20-mm thicknesses, breast 
phantom models of seven thicknesses ranging from 10 mm to 70 mm were created. A polymethyl 
methacrylate phantom was arranged around the periphery of the breast model to suppress the effect of 
scattered radiation, and the device was configured so the detector was completely covered (Fig. 1). 
 
4.2. Imaging of Breast-Equivalent Phantoms 
The phantoms (three tissue ratios, seven thicknesses) were imaged using FFDM (General Electric 
Senographe Essential F, Buc, France). Imaging was performed using the Auto Exposure Control imaging 
mode, which automatically selected the target/additional filter combinations (molybdenum [Mo]/Mo, 
Mo/rhodium [Rh], or Rh/Rh) and tube voltage for imaging. The imaging conditions (tube voltage, current 
time product [mAs value], and average glandular dose [AGD]) as displayed on the equipment were 
recorded. Each breast model was imaged thrice and the mean of each displayed value was calculated. 
 
4.3. CNR Measurements and Calculation 
CNR measurements were performed following the guidelines described in IEC 61223-3-2Ed.2.0 
[26]. A 99.9% pure aluminum plate (CIRS T43009) measuring 100 mm × 100 mm × 0.2 mm was placed at 
the center of the phantom as a contrast substance. Images were acquired with and without the aluminum 
plate in place for each breast model. A 20 mm × 20 mm rectangular region of interest (ROI) was marked 
along the central line on the longitudinal axis of the X-ray for the two captured images, corresponding to 
the nipple side and 60 mm away from the chest wall side of the breast support table. The average pixel 
value within the ROI was measured in both images (with and without the aluminum plate, Fig. 2) using 
ImageJ software (National Institutes of Health, Bethesda, MD).  
CNR values were calculated from the measured pixel values according to the following previously 
published equation (1) [27].  
                              (1) 
 
where  is the mean pixel value of the 20 × 20 mm ROI with the aluminum plate in position,  is 
the corresponding pixel value standard deviation, is the mean pixel value without the aluminum 
plate in place, and  is the corresponding pixel value standard deviation.  
 
4.4. Statistical Analysis 
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SAS JMP ver13.1.0 (SAS Institute, Cary, NC) and Student’s t test were used and p < 0.05 was 
considered significant for all statistical analyses. Residual sum of squares and multivariate (simple linear 
regression) analysis were performed with the mammary gland tissue ratio and AGD as independent 
variables and the CNR as the dependent variable to assess the effect of the mammary gland tissue ratio 
and AGD on CNR. The mean CNR at each mammary gland tissue ratio was adjusted by the AGD as a 
covariate and the difference in CNR values between different mammary gland tissue ratios was 
determined.  
Next, the correlation between the AGD and CNR was assessed for each mammary gland ratio. A strong 
positive correlation was defined as r ≥ 0.7. Using an Excel function, a prediction equation was obtained 
for each mammary gland ratio. Using the root mean square error (RMSE) analysis, prediction accuracy 
was assessed by comparing the predicted values of the CNR adjusted by the AGD with the actual CNR 
values for each mammary 
gland ratio. 
A multivariate (least squares method) analysis was performed with the mammary gland tissue ratio (30/70, 
50/50, 70/30) and AGD as independent variables and the CNR as a dependent variable to identify the 
factors associated with CNR. Factors with t-values below |2.00| were defined as not contributing 
significantly to the CNR. Additionally, larger absolute values were defined to have a greater contribution. 
A predictive formula of CNR was obtained by generalizing the analysis model. Predicted and measured 
values of the CNR were compared using the RMSE to evaluate the accuracy of the predictive formula.  
Finally, a multivariate linear regression model with the CNR as the objective variable and mammary gland 
ratio, AGD, and phantom thickness as the explanatory variables was constructed, with the intent to 
determine the correlation between the CNR and each measurement item. Additionally, analysis of 
variance based on the constructed multivariate linear regression model was conducted and the 
contribution rate for each of the variables was calculated. For the analysis of variance, the mammary 
gland ratio used AGD as the variable factor and phantom thickness as the continuous variable. R (v. 
3.2.4) was used for this analysis (R Foundation for Statistical Computing, Vienna, Austria) and Wald Test 
was used to estimate the regression coefficient and 95% confidence interval.  
 
5. Results  
Table 1 and Figure 3 show the imaging conditions and CNR values calculated for the three breast 
models with different tissue ratios and thicknesses. CNR values were highest in Phantom A (30/70) at all 
thicknesses. In general, higher CNR values were obtained with lower mammary gland ratios and lower 
phantom thicknesses. The variation in CNR among the three breast models was low (coefficient of 
variation, 3.4-8.7%) at lower phantom thicknesses (10–30 mm), and increased (coefficient of variation, 
10.5-16.8%) with increases in phantom thickness (50–70 mm). Notably, with a breast model thickness of 
70 mm, the CNR in breast model C (70/30) was 26% lower compared to that in breast model A (30/70). 
Table 2 shows the results of the multivariate analysis performed to investigate the effects of the mammary 
gland tissue ratio and AGD on the CNR. The p-values for the mammary gland ratio and AGD were < 
0.0476 and < 0.0001, respectively, showing statistical significance. The results showed that both the 
mammary gland ratio and AGD were significant predictors of CNR. 
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The mean CNR of each mammary gland ratio adjusted by the AGD as a covariate is shown in Table 3. The 
difference in CNR between mammary gland ratios is shown in Table 4. The p-value for the comparison 
between Phantoms A (30/70) and C (70/30) was 0.0213, showing a statistically significant difference in 
CNR between the two models. 
Figure 4 shows that there was a strong negative correlation (r = -0.8989) between the CNR and AGD 
across all three mammary gland ratios. In addition, a strong negative correlation (r = -0.8989) was also 
observed between the CNR and AGD at each mammary gland ratio. The prediction equations for the CNR 
based on the AGD values for each mammary gland ratio are provided in Table 5. The comparison between 
the predicted values of the CNR adjusted by AGD and the actual CNR values for each mammary gland 
ratio are shown in Figure 5 and Table 5. The accuracy of the CNR predicted by the mammary gland ratio 
was highest (r2 = 0.946, RMSE = 1.314) in Phantom B (50/50), followed by Phantom A (30/70) (r2 = 
0.928, RMSE = 1.323) and Phantom C (70/30) (r2 = 0.833, RMSE = 2.301).  
Based on the multivariate (least squares method) analysis of the mammary gland tissue ratio and AGD as 
independent variables and the CNR as a dependent variable, and on generalizing the analysis model, the 
CNR-predictive formula was obtained as follows (equations 2,3,4): 
 
Fibroglandular adipose mass (%) : 30/70  
    
                                 (2) 
 
Fibroglandular adipose mass (%) : 50/50     
 
                                 (3) 
 
Fibroglandular adipose mass (%) : 70/30     
 
                                 (4) 
 
This predictive formula revealed r2 = 0.865 and RMSE = 1.893, indicating that it is possible to predict the 
CNR using the AGD and mammary gland ratio. 
Table 6 shows that there was a significant correlation between the mammary gland ratio and phantom 
thickness and CNR (Regression coefficient 24.449, p value = 7.720E-13). The regression value was 
significantly lower for phantom C (Regression coefficient = -2.146, p value = 3.976E-03). The results 
suggest that the regression value significantly decreases as the phantom thickness increases (Regression 
coefficient = -0.228, p value = 8.041E-05). The phantom thickness contribution rate was 91.43%, which 
suggests that it can explain 91.43% of the CNR.  
Table 7 shows that there was a significant correlation between the mammary gland ratio and phantom 
thickness and CNR (Regression coefficient = 24.629, p value = 1.038E-17). The results show that the 
regression value was significantly lower for phantoms B (Regression coefficient = -1.3, p value = 
4.946E-02) and C (Regression coefficient = -2.157, p value = 2.684E-03). A decrease in the CNR value 
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with an increase in phantom thickness was observed.  
Table 8 shows that there was a significant correlation between the mammary gland ratio and AGD and 
CNR (Regression coefficient = 28.668, p value = 3.647E-13). The results suggest that the CNR value was 
significantly lower for phantom C (Regression coefficient = -2.559, p value = 2.178E-02). A significant 
decrease in the CNR value was observed along with the increase in AGD value. A comparison of the 
results with the Akaike's Information Criterion value, which expresses the goodness of fit of the model, 
showed that using phantom thickness as the explanatory variable produces a better model than using the 
AGD as the explanatory variable. 
 
6. Discussion 
In this study, we investigated the CNR and AGD of mammography using breast-equivalent 
phantoms with different tissue ratios and thicknesses. Our results showed that higher CNR values were 
obtained with breast-equivalent phantoms having lower mammary gland tissue ratios and lesser thickness. 
The CNR values showed a strong negative correlation with AGD values. These results corroborate 
previous reports of reduced 
cancer diagnosis sensitivity and poor MMG image quality in high-density mammary glands [13,16,17]. 
CNR is generally considered to be an index of image quality in various diagnostic imaging devices [28]. 
Image quality should also undergo manual evaluation, as image processing and image displays can 
significantly affect image quality in digital imaging equipment. Breast thickness is an important factor 
affecting image quality [16,17]. The average breast thickness has been reported to vary from 37.7 mm in 
Japanese women [29] to 45 mm in American women, 52 mm in British women, and 56 mm in German 
women [30]. Most FFDM use an automatic imaging mode that automatically selects targets/additional 
filters based on breast thickness to optimize exposure [31]. Therefore, the effect of breast thickness on 
CNR is often missed. Our results can be extrapolated to such clinical situations, where the effect of 
breast thickness on CNR can be estimated using AGD as an explanatory variable. Our results suggest 
that CNR prediction based on the tissue ratio could be used as a yardstick to evaluate the diagnostic 
reliability of MMG in breast cancer. CNR could be used as a post-processing index to objectively control 
for the effect of the mammary gland ratio and thickness on image quality and improve the reliability of 
diagnosis that is otherwise subjective and dependent on the mammography readers.  
Our study findings closely relate to previous studies that show the effect of breast density on 
mammographic sensitivity [13,16,17]. These studies show that sensitivity of mammographic detection 
declines with increasing breast density and that adjunct screening methods like ultrasonography could be 
used to increase detection sensitivity. Another study that evaluated the effect of breast thickness on 
AGD and CNR reported results complementary to our findings [25]. They showed that with increasing 
breast thickness, AGD values increase and CNR values decrease. Our study extends these results and 
establishes a predictive formula for CNR based on AGD, which has high accuracy and precision (R2 of 
0.865 and RMSE of 1.893). Our results show that both mammary gland ratio and AGD are significant 
predictors of CNR, with AGD having a greater effect on CNR. Interestingly, our results also show that 
variation of CNR within the three breast tissue models is low at low phantom thickness (10-30 mm; 
10 
 
coefficient of variation: 3.4-8.7%) and increases with increased phantom thickness (50~70 mm; coefficient 
of variation: 10.5-16.8%). This suggests that breast thickness might be a strong predictor of CNR, 
independent of the tissue density.  
Finally, multiple logistic regression analysis results showed that mammary gland ratio and phantom 
thickness were significantly correlated with CNR. To ensure that each variable was incorporated in the 
analysis model independently and to avoid inferior results from incorporating related variables into the 
analysis model at the same time, we conducted the regression analysis using two additional models, where 
the first model incorporated phantom thickness and the second model incorporated the AGD.  
This study has several limitations. First, there is the inherent limitation of a basic research study using 
phantoms. Phantoms have uniform tissue ratios and do not possess the heterogeneity of mammary gland 
density distribution encountered in the human breast [21]. The results of this study will require clinical 
validation in human subjects. Second, MMG was performed using a single FFDM device; therefore, it may 
not be possible to directly apply or extrapolate the results to other MMG devices. Third, we used a 
high-contrast aluminum plate for CNR measurement and investigated only the spatial resolution aspect, 
but not the density resolution aspect, of contrast resolution. CNR evaluates the signal difference between 
the two surfaces and the noise ratio of the obtained image. Therefore, CNR is not considered to provide 
sharpness information. It is also essential to investigate image features like density resolution and 
visibility. Since ultrasound examination is known to improve diagnostic reliability in dense breasts, future 
studies should investigate the role of the CNR in 
approaches combining ultrasound examinations and MMG for breast cancer screening [32].  
CNR is one of the image assessments under mammography. The CNR value cannot be obtained without 
using phantom. On the other hand, AGD appears on the mammography monitor under FFDM. This value 
can be easily obtained. Thus, applying the computation expression obtained under this research will 
enable us to easily obtain the CNR from the AGD value in real time immediately after mammography. 
Originally, the MMG observer used to make subjective evaluations based on the image contrast and noise. 
However, having the CNR value will enable more objective observations of images and this is anticipated 
to improve the diagnostic performance of cancer. 
 
7. Conclusions 
In this investigation we demonstrated that CNR varies inversely with mammary gland to fat tissue 
ratio and breast tissue thickness, which explains the clinical observation of poor MMG image quality in 
dense breasts. We also demonstrated a significant correlation between the CNR and AGD based on the 
tissue ratio and developed a predictive formula for CNR using AGD and mammary gland density. CNR 
prediction based on the tissue ratio could be used as a yardstick to measure the diagnostic reliability of 
MMG in breast cancer, objectively control for the effect of mammary gland ratio on image quality and 
improve the reliability of diagnosis that is otherwise subjective.  
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Tables 
Table 1: CNR values based on mammary gland density and imaging conditions  
Fibroglandular 
adipose mass (%) 
Thickness of 
phantom (mm) 
Target  
filter 
Tube voltage 
(kV) 
mAs
(mAs) 
AGD 
(mGy) 
CNR 
Phantom A 
(30/70) 
10 Mo/Mo 26 16.7 0.48 23.1 
20 26 27.9 0.75 20.1 
30 Mo/Rh 27 41.7 1.01 16.2 
40 28 57.1 1.27 15.1 
50 Rh/Rh 29 60.8 1.33 13.0 
60 29 74.9 1.58 11.7 
70 30 90.2 1.95 10.9 
Phantom B 
(50/50) 
10 Mo/Mo 26 18 0.53 21.8 
20 26 34 0.85 20.8 
30 Mo/Rh 27 47.2 1.07 16.0 
40 Rh/Rh 29 50.1 1.2 13.7 
50 30 52.4 1.23 11.4 
60 31 59.7 1.49 9.6 
70 30 75 1.47 8.4 
Phantom C 
(70/30) 
10 Mo/Mo 26 19.1 0.54 21.8 
20 26 37.8 0.87 19.1 
30 Mo/Rh 27 44 0.9 13.8 
40 Rh/Rh 29 59.7 1.23 12.6 
50 30 69 1.55 10.6 
60 30 64 1.29 9.0 
70 30 95.3 1.73 8.1 
AGD: average glandular dose, CNR: contrast to noise ratio, Mo: molybdenum, Rh: rhodium 
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Table 2: Results of the multivariate analysis for effect of mammary gland density and 
AGD on CNR 
Variables Parameter df Sum of squares F value p 
Mammary gland tissue ratio 2 2 26.3 3.66 0.0476 
AGD 1 1 376.6 105.06 < 0.0001 
AGD: average glandular dose, CNR: contrast to noise ratio, df: Degrees of Freedom 
 16 
 
 
Table 3: Mean CNR for each mammary gland tissue ratio adjusted by the AGD as a covariate. 
Breast phantom model 
(Fibroglsndular 
/adipose ratio) 
CNR Unadjusted 
difference  
[95%CI] 
p CNR Adjusted for  
AGD difference 
 [95%CI] 
p 
A (30/70) 15.73 -1.3 
[-6.84, 4.24] 
0.6274 16.14 -0.92 
[-2.23, 0.39] 
0.1459 
B (50/50) 14.43 15.22 
C (70/30) 13.57 -2.17 
[-7.7, 3.37] 
0.4217 16.14 -2.66 
[-4.03, -1.29] 
0.0017 
13.48 
A (30/70) 15.73 
B (50/50) 14.43 -0.87 
[-6.4, 4.67] 
0.7465 15.22 -1.74 
[-2.5, -0.98] 
0.0006 
C (70/30) 13.57 13.48 
p value: Student’s t-test. AGD: average glandular dose, CNR: contrast to noise ratio 
 17 
 
 
Table 4: Pairwise differences in the CNR between phantoms with different mammary gland 
ratios 
 CNR difference [95%CI] p 
A (30/70) vs. B (50/50) -2.12 [-4.26, 0.02] 0.0521 
A (30/70) vs. C (70/30) -2.57 [-4.71, -0.43] 0.0213 
B (50/50) vs. C (70/30) -0.45 [-2.59, 1.69] 0.6637 
CNR: contrast to noise ratio, CI: confidence interval 
 18 
 
 
Table 5: Predictive formulae for CNR according to breast density 
Breast phantom model    
(Fibroglandular 
/adipose ratio) 
Correlation with CNR 
CNR predictive formula R2 RMSE r p 
A (30/70) -0.9631 
 
CNR = -8.69 AGD+26.12 
0.928 1.323 
B (50/50) -0.9724 
 
CNR = -14.62 AGD+30.80 
0.946 1.314 
C (70/30) -0.9126 
 
CNR = -11.29 AGD+26.64 
0.833 2.301 
Model: p < 0.0001, R2 = 0.865, RMSE = 1.893. CNR: contrast to noise ratio, RMSE: root 
mean square error 
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Table 6: Results of multivariate linear regression analysis using CNR as the objective variable, and mammary gland ratio, AGD, and 
phantom thickness as the explanatory variables 
  
Regression  
results    
Analysis of  
variance  
Variable Level Regression coefficient 
Lower limit of  
95% confidence interval 
Upper limit of  
95% confidence interval 
Wald test 
p value 
Contribution  
rate 
Chi-squared test p value 
Constant term - 24.489 21.929 27.049 7.720E-13 - - 
Phantom type B -1.276 -2.665 0.112 6.911E-02 3.63% 1.213.E-02 
Phantom type C -2.146 -3.499 -0.792 3.976E-03 - - 
Phantom thickness - -0.228 -0.321 -0.136 8.041E-05 91.43% 9.500.E-12 
AGD - 0.311 -4.402 5.025 8.904E-01 0.01% 8.904.E-01 
AGD: average glandular dose, CNR: contrast to noise ratio 
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Table 7: Results of multivariate linear regression analysis using CNR as the objective variable and phantom type and phantom thickness 
as the explanatory variables 
  
Regression  
results    
Analysis of  
variance  
Variable Level 
Regression  
coefficient 
Lower limit of  
95% confidence interval 
Upper limit of  
95% confidence interval 
Wald test p  
value 
Contribution 
rate 
Chi-squared  
test p value 
Constant term - 24.629 23.228 26.029 1.038.E-17 - - 
Phantom type B -1.3 -2.597 -0.003 4.946.E-02 3.63% 9.247.E-03 
Phantom type C -2.157 -3.454 -0.861 2.684.E-03 - - 
Phantom thickness - -0.223 -0.249 -0.196 2.108.E-12 91.43% 2.108.E-12 
AIC 71.01658, CNR: contrast to noise ratio, AIC: Akaike's Information Criterion 
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Table 8: Results of multivariate linear regression analysis using CNR as the objective variable and phantom type and AGD as the 
explanatory variables 
  
Regression  
results    
Analysis of  
variance  
Variable Level 
Regression  
coefficient 
Lower limit of  
95% confidence  
interval 
Upper limit of 
95% confidence  
interval 
Wald test p  
value 
Contribution  
rate 
Chi-squared  
test p value 
Constant term - 28.668 25.607 31.729 3.647.E-13 - - 
Phantom type B -2.119 -4.262 0.024 5.230.E-02 3.63% 1.305.E-01 
Phantom type C -2.559 -4.697 -0.421 2.178.E-02 - - 
AGD - -10.822 -13.048 -8.595 1.070.E-08 82.96% 1.070.E-08 
AIC: 99.99013, AGD: average glandular dose, CNR: contrast to noise ratio, Akaike's Information Criterion   
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Figure legends 
Fig. 1 Experimental set up of the phantom for the CNR measurement based on the 
International Electrotechnical Committee guidelines (a) without, and (b) with the 
aluminum plate placed at the center of the horizontal axis of the breast support. 
CNR: contrast to noise ratio, PMMA: polymethyl methacrylate 
 
Fig. 2 Schematic showing the region of interest (ROI) in the breast-equivalent phantom 
(a) without and (b) with the aluminum plate. Pixel values were calculated using ImageJ 
in the ROI without (BG-ROI), and with (Al-ROI) the aluminum plate 
 
Fig. 3 Contrast to noise ratio (CNR) measurement results in breast phantoms with three 
different tissue ratios plotted against phantom thickness. The CNR was highest in 
phantom model A (30/70) at all thicknesses. The CNR decreased as the mammary gland 
density increased, and the thickness of the breast model increased. Mo: molybdenum, 
Rh: rhodium 
 
Fig. 4 Correlation between the AGD and CNR (a) across all three mammary gland ratios, 
and in (b) model A (30/70), (c) model B (50/50), and (d) model C (70/30). AGD: average 
glandular dose, CNR: contrast to noise ratio 
 
Fig. 5 Correlation between the CNR predicted value measured at different tissue ratios 
in (a) model A (30/70), (b) model B (50/50), and (c) model C (70/30). CNR: contrast 
to noise ratio 
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